This site is intended for Healthcare professionals only.

Valeant Pharma reports quarterly loss, to change name to Bausch Health


Valeant Pharma reports quarterly loss, to change name to Bausch Health

Valeant Pharmaceuticals International Inc reported first-quarter loss compared with a year-ago profit and said on Tuesday it would change its name to Bausch Health Companies Inc.

Net loss attributable to the company was at $2.69 billion, or $7.68 per share, in the quarter ended March 31, compared with a profit of $628 million, or $1.79 per share, a year earlier.

Total revenues fell 5.4 percent to $1.96 billion.



Source: REUTERS
0 comment(s) on Valeant Pharma reports quarterly loss, to change name to Bausch Health

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted